Persei vivarium participated in the 5th Capital Cell Biotech Investment Forum. Under the leadership of its CEO, Roberto Bravo, Persei vivarium has become one of the most innovative companies in the biotechnology sector, and he presented the company to the other participants.
The 5th Biotech Investment Forum, organized by Capital Cell, has become a meeting point for companies in the biotechnology sector and investors, who are able to learn about different projects and participate in networking sessions.
Capital Cell is the leading European equity crowdfunding platform, specialized in biotechnology and health projects.
Since 2015, Capital Cell has carried out 13 investment rounds for a total of more than €4M for businesses that are bringing to market new treatments for childhood cancer, Alzheimer’s, schizophrenia, and multiple sclerosis, among other diseases.